X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse FDC LTD. with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 FDC LTD.   TEVA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TEVA PHARMA
Dec-13
FDC LTD./
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1442,869-   
Low Rs792,493-   
Sales per share (Unadj.) Rs47.61,646.7-  
Earnings per share (Unadj.) Rs7.6102.9-  
Cash flow per share (Unadj.) Rs9.0236.0-  
Dividends per share (Unadj.) Rs2.2590.05-  
Dividend yield (eoy) %2.03.4 60.2%  
Book value per share (Unadj.) Rs47.51,829.1-  
Shares outstanding (eoy) m177.83848.00-   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.31.6 143.7%   
Avg P/E ratio x14.626.1 56.1%  
P/CF ratio (eoy) x12.311.4 108.7%  
Price / Book Value ratio x2.31.5 159.7%  
Dividend payout %29.687.5 33.8%   
Avg Mkt Cap Rs m19,7842,273,369 0.9%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m1,2210-   
Avg. sales/employee Rs ThNM31,068.7-  
Avg. wages/employee Rs ThNM0-  
Avg. net profit/employee Rs ThNM1,940.8-  
INCOME DATA
Net Sales Rs m8,4591,396,384 0.6%  
Other income Rs m3940-   
Total revenues Rs m8,8521,396,384 0.6%   
Gross profit Rs m2,070382,401 0.5%  
Depreciation Rs m249112,871 0.2%   
Interest Rs m3127,427 0.1%   
Profit before tax Rs m2,184242,102 0.9%   
Minority Interest Rs m01,100 0.0%   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-158,927 0.0%   
Tax Rs m606-2,956 -20.5%   
Profit after tax Rs m1,35387,231 1.6%  
Gross profit margin %24.527.4 89.4%  
Effective tax rate %27.7-1.2 -2,271.4%   
Net profit margin %16.06.2 256.1%  
BALANCE SHEET DATA
Current assets Rs m4,355943,113 0.5%   
Current liabilities Rs m1,792822,474 0.2%   
Net working cap to sales %30.38.6 350.8%  
Current ratio x2.41.1 212.0%  
Inventory Days Days4491 49.0%  
Debtors Days Days2596 25.7%  
Net fixed assets Rs m3,025456,090 0.7%   
Share capital Rs m1793,437 5.2%   
"Free" reserves Rs m8,2430-   
Net worth Rs m8,4531,551,118 0.5%   
Long term debt Rs m11714,002 0.0%   
Total assets Rs m10,5573,191,186 0.3%  
Interest coverage x71.49.8 726.7%   
Debt to equity ratio x00.5 0.3%  
Sales to assets ratio x0.80.4 183.1%   
Return on assets %13.13.6 364.9%  
Return on equity %16.05.6 284.6%  
Return on capital %23.54.9 476.7%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Net fx Rs m7910-   
CASH FLOW
From Operations Rs m1,485222,511 0.7%  
From Investments Rs m-620-78,845 0.8%  
From Financial Activity Rs m-753-266,917 0.3%  
Net Cashflow Rs m113-123,251 -0.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.74 Rs / USD

Compare FDC LTD. With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare FDC LTD. With: J.B.CHEMICALS  DIVIS LABORATORIES  ALEMBIC LTD  GSK PHARMA  NOVARTIS  



Today's Market

Of IPOs, LIC-IDBI Bank Deal, and Top Cues in Focus Today(Pre-Open)

Share markets in India closed marginally higher on Friday last week. All sectoral indices traded in green, with stocks in the IT sector and stocks in the pharma sector, leading the gains.

Related Views On News

FDC LTD. Announces Quarterly Results (4QFY18); Net Profit Down 35.8% (Quarterly Result Update)

Jul 20, 2018 | Updated on Jul 20, 2018

For the quarter ended March 2018, FDC LTD. has posted a net profit of Rs 315 m (down 35.8% YoY). Sales on the other hand came in at Rs 3 bn (up 5.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

Sintex's Auditor Resigns. How You Can Protect Yourself from Such Stocks(The 5 Minute Wrapup)

Jul 20, 2018

While the attack on the bad corporate governance is an overhang in the near term...this can be a game-changer in the years to come.

The Answer to Your Wealth Worries: Small Caps (Especially Now)(Profit Hunter)

Jul 10, 2018

If you're worried about the markets - you are on the wrong track. This is opportunity - put your wealth-building hat on, instead - Richa shows you how...

The Multiple Problems with the Minimum Support Price (MSP) System(Vivek Kaul's Diary)

Jul 11, 2018

The price signals that MSP sends out, creates its own set of problems.

PPF v/s Mutual Funds: Which Is Better?(Outside View)

Jul 10, 2018

PersonalFN highlights the key points of distinction between PPF and mutual funds.

ICICI Pru Mutual Fund Tarakki Karega! - The Unethical Way?(Outside View)

Jul 11, 2018

PersonalFN explains how ICICI Prudential Mutual Fund flouted the norms of related party transactions while subscribing to the IPO of ICICI Securities.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jul 20, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS